Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ZEMURON

ROCURONIUM BROMIDE

Standard Dose
50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ZEMURON is listed in Drugs@FDA under application 020214 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ROCURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2018-07-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZEMURON is listed in Drugs@FDA under application 020214 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ROCURONIUM BROMIDE Form and strength INJECTABLE;INJECTION - 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ORGANON USA INC Submission history Latest submission status date: 2018-07-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.